StockData
Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc. (PLRX) stock

PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$0.66+0.00 (+0.12%)

Close on Nov 18, 2026Market cap $40.93MP/E –Yield 0.00%

Pliant Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Pliant Therapeutics's pe ratio was 1.2× on Jan 29, 2021.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Jan 29, 20211.2×+0.1
2020Dec 31, 20201.1×–

More Pliant Therapeutics figures

See a number that looks wrong?